Update in Internal Medicine 2023 (RP2304C)

Dallas, TX US
April 22, 2023

About the Conference
Internal medicine is expanding at a fast pace as new therapies are developed and new guidelines and standards of care are recommended across a spectrum of diseases. Busy physicians and internists are faced with the growing challenge of keeping abreast of all the advances. The annual Update in Internal Medicine conference is designed to help clinicians meet the challenge by offering state-of-the-art, practical advice on common conditions and exciting new developments.

The conference is presented in a hybrid learning approach: a one-day live and synchronous online presentation (Saturday, April 22, 2023) as well as pre-recorded on-demand presentations.  All content will be available for up to one year totaling 17 hours CME credit and the opportunity to apply for MOC credit per ABIM requirements.

YOU MAY REGISTER TO ATTEND IN-PERSON OR VIRTUALLY!

Click on the "REGISTER" tab above. When the Registration Page appears, select your appropriate category/fee and also select how you will attend the conference.

Target Audience

This CME Conference is designed for: primary care providers, nurse practitioners, physician assistants, and specialists in Internal Medicine and Family Practice seeking updates in practical knowledge relating to patient care.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Understand the appropriate indications for use of PPI in primary care and when these medications can be stopped safely.
  • List appropriate indications for thrombophilia testing in patients with first episode of venous thromboembolism.
  • Apply evidence-based approach to use of SGLT-2 and GLP-1 therapies in patients with cardiovascular or renal risk factors or disease.
  • Develop a practical approach to take an antibiotic allergy history and remove unnecessary penicillin allergy labels.
  • Understand the drivers of vaccine hesitancy and practical strategies to address concerns raised over vaccines.
  • Describe roles of abdominal imaging and genetic testing for screening and diagnosis of Autosomal Dominant Polycystic Kidney Disease (ADPKD).
  • Develop a systematic approach to initial diagnostic workup for suspected interstitial lung disease.
  • List indications for imaging and referral to specialist for common MSK complaints.
  • Explain the roles of lifestyle management and pharmacologic therapy in patient weight management in primary care.

Additional Information

AttachmentSize
PDF icon UIM2023-BROCHURE+AGENDA-final.pdf18.99 MB
Course summary
Available credit: 
  • 17.50 AMA
  • 17.50 Attendance
  • 1.00 Ethics
Course opens: 
02/16/2023
Course expires: 
03/31/2024
Event starts: 
04/22/2023 - 8:00am CDT
Event ends: 
04/22/2023 - 3:00pm CDT
Cost:
$299.00
Rating: 
0

CLICK HERE TO VIEW CME HANDOUT  

(includes agenda, learning objectives, speaker listing, disclosures, CME-Ethics-MOC credit information, etc.)

This conference is presented in a hybrid learning approach: a one-day live and synchronous online presentation (Saturday, April 22, 2023) as well as pre-recorded on-demand presentations.  

All content will be available for up to one year totaling 17.5 hours CME credit and the opportunity to apply for MOC credit per ABIM requirements.

 

LIVE PRESENTATIONS - Saturday, April 22, 2023

(click on presentation title to access pdf slides)

 

UT Southwestern Medical Center
T. Boone Pickens Auditorium (NG3.112)
6001 Forest Park Road
Dallas, TX 75235
United States

Course Directors:

James "Brad" Cutrell, M.D.

Vlad Zaha, M.D.

 

Course Director(s)

James Cutrell, MD

has no relevant financial relationships to disclose at this time.

Vlad Zaha, MD, PhD

has no relevant financial relationships to disclose at this time.
Speaker(s)

Traci Adams, Assistant Professor of Medicine, Division of Pulmonary and Critical Care Medicine

has no relevant financial relationships to disclose at this time.

Ariel Aday, MD

has no relevant financial relationships to disclose at this time.

Bethany Agusala, MD

has no relevant financial relationships to disclose at this time.

Sadia Ali, MD

has no relevant financial relationships to disclose at this time.

Jaime Almandoz, MD

has a financial relationship (Independent contractor) with NovoNordisk;.
has a financial relationship (Independent contractor) with Eli Lilly and Co;.

Anthony Bavry, MD MPH

has no relevant financial relationships to disclose at this time.

Luigino Bernabela, MD, RhMSUS

has no relevant financial relationships to disclose at this time.

Jason Clark

has no relevant financial relationships to disclose at this time.

Suzanne Cole, MD

has no relevant financial relationships to disclose at this time.

kathryn dao, MD, FACP, FACR

has a financial relationship (Independent contractor) with Bristol Myers Squibb ;.
has a financial relationship (Independent contractor) with RheumNow;.
has a financial relationship (Independent contractor) with Novartis;.

Sandeep Das, MD, MPH, MBA

has no relevant financial relationships to disclose at this time.

Kerry Dunbar, MD, PhD

has no relevant financial relationships to disclose at this time.

Tara DuVal

has no relevant financial relationships to disclose at this time.

Benjamin Elsbernd, MD

has no relevant financial relationships to disclose at this time.

Carolee Estelle, MD

has no relevant financial relationships to disclose at this time.

Kara Goss, MD

has no relevant financial relationships to disclose at this time.

Judah Gruen, Assistant Professor of Internal Medicine

has no relevant financial relationships to disclose at this time.

Sandra Hofmann

has no relevant financial relationships to disclose at this time.

David Khan

has a financial relationship (Professional Services) with UpToDate;.
has a financial relationship (Financial Support) with JACI In Practice;.

Ronak Lakhia

has no relevant financial relationships to disclose at this time.

Benjamin Levine, Professor of Medicine

has no relevant financial relationships to disclose at this time.

Ildiko Lingvay, MD, MPH, MSCS

has a financial relationship (Independent contractor) with NovoNordisk, AstraZeneca, BI, Lilly, Valeritas, Intarcia, Mannkind, Janssen, Intercept, Zealand Pharma, Bayer, TARGETPharma, Duke CRI, ADA;.
has a financial relationship (Grant Or Contract) with NovoNordisk, Pfizer, Merck, Mylan, Sanofi;.

Katy Lonergan

has no relevant financial relationships to disclose at this time.

Yazan Madanat

has a financial relationship (Professional Services) with OncLive;.
has a financial relationship (Professional Services) with Bluprint Pharmaceuticals;.
has a financial relationship (Professional Services) with Stemline Therapeutics ;.
has a financial relationship (Professional Services) with GERON;.

Meredith McAdams, MD

has no relevant financial relationships to disclose at this time.

Mack Mitchell, MD

has a financial relationship (Stock Options) with Amygdala Neuroscience ;.
has a financial relationship (Stock) with Moderna;.

Alecia Nero, MD, MSCS, FACP

has a financial relationship (Independent contractor) with Global Blood Therapeutics;.
has a financial relationship (Independent contractor) with Editas Medicine;.
has a financial relationship (Independent contractor) with Bluebird Bio;.
has a financial relationship (Independent contractor) with Novartis Pharmaceuticals;.

David Sher, MD, MPH

has a financial relationship (Grant Or Contract) with Varian Medical Systems;.

Madhuri Sopirala, MD, MPH, FIDSA, FACP

has no relevant financial relationships to disclose at this time.

Accreditation Statement

The University of Texas Southwestern Medical Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statements

The University of Texas Southwestern Medical Center designates this live educational activity for a maximum of 17.5 AMA PRA Category1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The University of Texas Southwestern Medical Center certifies that non-physicians will receive an attendance certificate stating that they participated in the activity that was designated for 17.5 AMA PRA Category 1 Credit™.

Available Credit

  • 17.50 AMA
  • 17.50 Attendance
  • 1.00 Ethics

Price

Cost:
$299.00
Please login or create an account to take this course.

Registration

To register:

  1. Login to your existing account or create an account in EthosCE, online learning management system, by selecting the "create an account" link.
  2. Once logged in, return to this course page, select the designated fee and click the "add to cart" button.
  3. In the following "checkout" pages you will verify and process your payment.
  4. After registration is completed, a confirmation will be sent by email.